Arca
Skip to content

Prostatitis

Drug research and approvals for prostatitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 8 studies of prostatitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 8
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 8 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

4 approved, 4 in phase 3, 7 in phase 2, 2 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Ciprofloxacin, Flavoxate, Cephalexin anhydrous, Cefazolin

Levofloxacin anhydrous
Phase 3 DNA gyrase inhibitor
Onabotulinumtoxina
Phase 3 Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
Alfuzosin
Phase 3 Adrenergic receptor alpha-1 agonist
Pregabalin
Phase 3 Voltage-gated calcium channel modulator
Silodosin
Phase 2 Alpha-1a adrenergic receptor antagonist
Tamsulosin
Phase 2 Adrenergic receptor alpha-1 antagonist
Dutasteride
Phase 2 Steroid 5-alpha-reductase inhibitor
Apremilast
Phase 2 Phosphodiesterase 4 inhibitor
Tanezumab
Phase 2 Beta-nerve growth factor inhibitor
Prulifloxacin
Phase 2 Bacterial DNA gyrase inhibitor
Cetirizine
Early phase 1 Histamine H1 receptor antagonist
Cromolyn
Early phase 1 Unknown

How Its Trials Ended

87 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 23 whose ending is known, 35% met their primary endpoint, 13% missed it and 52% stopped early.

  • Completed, result not reported3641%
  • Status unknown1720%
  • Ongoing1113%
  • Met its primary endpoint89%
  • Stopped: other or unclear67%
  • Stopped: enrollment or feasibility56%
  • Missed its primary endpoint33%
  • Stopped: sponsor or business decision11%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.